Gert J. Meersma
Groningen, GR 9713GZ, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts.
Journal: Scientific reports
Published: September 09, 2024
Ultrasound-Guided Quantitative Fluorescence Molecular Endoscopy for Monitoring Response in Patients with Esophageal Cancer Following Neoadjuvant Chemoradiotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 20, 2024
Genome-wide DNA methylation in relation to ARID1A deficiency in ovarian clear cell carcinoma.
Journal: Journal of translational medicine
Published: December 21, 2023
Bevacizumab-IRDye800CW for tumor detection in fluorescence-guided meningioma surgery (LUMINA trial): a single-center phase I study.
Journal: Journal of neurosurgery
Published: December 02, 2023
Feasibility of bevacizumab-IRDye800CW as a tracer for fluorescence-guided meningioma surgery.
Journal: Journal of neurosurgery
Published: May 03, 2022
Validation of Novel Molecular Imaging Targets Identified by Functional Genomic mRNA Profiling to Detect Dysplasia in Barrett's Esophagus.
Journal: Cancers
Published: April 06, 2022
Establishment and characterisation of testicular cancer patient-derived xenograft models for preclinical evaluation of novel therapeutic strategies.
Journal: Scientific reports
Published: March 19, 2020
C-Met targeted fluorescence molecular endoscopy in Barrett's esophagus patients and identification of outcome parameters for phase-I studies.
Journal: Theranostics
Published: November 18, 2019
Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma.
Journal: Cancer letters
Published: May 22, 2019
Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment.
Journal: Molecular cancer therapeutics
Published: April 25, 2019
Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 27, 2017
Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer.
Journal: BMC medicine
Published: January 13, 2017
Last Updated: 09/26/2026